PROM1 and glioblastoma: First, the near identical growth properties of CD133- and CD133+ cells in all 16 tumors is difficult to reconcile with numerous studies showing that the CD133+ fraction contains the self-renewing population in the vast majority of CD133+ GBM tumors [51,80,81].